Telemedicine to Improve Use of Therapeutic Hypothermia in Rural Settings

  • End date
    Dec 31, 2023
  • participants needed
  • sponsor
Updated on 15 February 2022


This pilot intervention trial will assess the feasibility of a live consultation between community hospital providers and tertiary care providers employing a novel teleconsult platform, Maine Neonatal Encephalopathy Teleconsult (Maine NET), on the time to initiation of therapeutic hypothermia (TH) for 10 infants born in community hospitals in Maine compared with matched historical controls. Community hospital providers and tertiary care center provider satisfaction with the Maine NET platform will also be assessed. We hypothesize that immediately available expert assessment via a teleconsult platform will promote earlier implementation of TH and be associated with high levels of provider satisfaction.

Condition Neonatal Encephalopathy
Treatment Telemedicine consult
Clinical Study IdentifierNCT03706417
Last Modified on15 February 2022


Yes No Not Sure

Inclusion Criteria

Infants included in this study will be born at a community hospital, will be
in either high or moderate risk, will be younger than 6 hours of age at the
time of the consultation and the decision will have been made to treat with
TH. High risk infants will be defined as an umbilical cord pH of less than or
equal to 7.0 or 5 minute APGAR score of less than or equal to 5 or a need for
resuscitation (including respiratory support or chest compressions) or an
abnormal exam (which may include flaccid tone, poor suck reflex or poor
response to stimulation) or seizures at less than 6 hours of life. Moderate
risk infants will be defined as an umbilical cord pH of less than or equal to
2 but greater than 7.0 or 5 minute APGAR score of less than 7 but greater
than 5 or a perinatal event (such as placental abruption, uterine rupture
cord prolapse, or fetal-maternal hemorrhage) or an abnormal exam (which may
include a hyper-alert state)

Exclusion Criteria

Infants older than 6 hours at the time Maine NET is requested and infants for
whom TH is not an appropriate therapy (e.g. due to premature birth or moribund
status) will be excluded
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact



Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note